Alpine Global Management’s Zimmer Biomet ZBH Stock Holding History

Alpine Global Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,899	Closed	-$220K	–	436
2020 Q2	$220K	Buy	+1,899	New	+$219K	0.04%	263
2016 Q1	–	Sell	-9,173	Closed	-$914K	–	205
2015 Q4	$914K	Buy	9,173 +5,721	+166%	+$560K	0.29%	53
2015 Q3	$315K	Buy	3,452 +2,661	+336%	+$267K	0.09%	64
2015 Q2	$84K	Sell	791 -3,153	-80%	-$349K	0.01%	630
2015 Q1	$450K	Sell	3,944 -793	-17%	-$90.5K	0.15%	153
2014 Q4	$522K	Buy	4,737 +1,925	+68%	+$203K	0.09%	248
2014 Q3	$275K	Buy	+2,812	New	+$277K	0.21%	92

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Alpine Global Management's ZBH Position: Q3 2020 in Review

Alpine Global Management sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 1,899 shares — an estimated $220K sold.

Alpine Global Management first reported a position in ZBH in Q3 2014 and held it in 7 quarters. The position peaked at $914K in Q4 2015. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

Alpine Global Management reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
Alpine Global Management sold 1,899 Zimmer Biomet shares in Q3 2020, an estimated $220K.
Alpine Global Management first reported a position in Zimmer Biomet in Q3 2014 and held it in 7 quarters.
Alpine Global Management's Zimmer Biomet position peaked at $914K in Q4 2015.
930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Alpine Global Management's 13F filing for Q3 2020, filed 12 Nov 2020.